Bacterial infections complicating liver disease

Area of Science:

• Hepatology
• Infectious Diseases
• Critical Care Medicine

Background:

• Bacterial infections pose a significant threat to patients with liver disease, increasing mortality risk through complications like gastrointestinal bleeding, renal failure, and hepatic encephalopathy.
• Patients with alcoholic cirrhosis, decompensated chronic liver disease, or fulminant hepatic failure are at the highest risk.
• Infections can manifest subtly as general deterioration, worsening encephalopathy, or renal impairment, necessitating high clinical suspicion.

Purpose of the Study:

• To review the epidemiology, clinical presentation, and management of bacterial infections in patients with liver disease.
• To highlight common and overlooked infections, risk factors, and impaired host defense mechanisms.
• To discuss current and promising treatment strategies, including antibiotics and adjuvant therapies.

Main Methods:

• Literature review and synthesis of existing data on bacterial infections in liver disease.
• Analysis of common infection sites, causative organisms, and risk factors.
• Evaluation of diagnostic indicators, such as ascitic fluid polymorphonuclear cell (PMN) count.

Main Results:

• Bacteraemia, pneumonia, urinary tract infections, and spontaneous bacterial peritonitis are most common; endocarditis and meningitis can be overlooked.
• Gram-negative enteric organisms and streptococci (especially pneumococci) are the most frequent pathogens; anaerobes are rare.
• Impaired reticuloendothelial system, complement, and PMN function, along with humoral immunity defects, compromise host defenses.

Conclusions:

• Bacterial infections are a critical determinant of outcome in liver disease patients, requiring vigilant monitoring and prompt intervention.
• Spontaneous bacterial peritonitis can occur without typical peritonitis signs, making ascitic fluid analysis essential.
• Adjuvant gut sterilization and supportive therapies show promise in improving treatment efficacy and reducing infection risk, despite high mortality rates.